Fluvoxamine for outpatient management of COVID-19 to prevent hospitalization: a systematic review and meta-analysis

TC Lee, S Vigod, É Bortolussi-Courval… - JAMA network …, 2022 - jamanetwork.com
Importance Widely available and affordable options for the outpatient management of COVID-19
are needed, particularly for therapies that prevent hospitalization. Objective To perform …

Inhaled corticosteroids for outpatients with COVID-19: a meta-analysis

TC Lee, É Bortolussi-Courval, S Belga… - European …, 2022 - Eur Respiratory Soc
Inhaled corticosteroids have received substantial interest as treatments for non-hospitalised
patients presenting with symptomatic SARS-CoV-2 infections, following two open label …

The MedSafer study—electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial

…, MG Wilson, É Bortolussi-Courval… - JAMA internal …, 2022 - jamanetwork.com
Importance Scalable deprescribing interventions may reduce polypharmacy and the use of
potentially inappropriate medications (PIMs); however, few studies have been large enough …

Drug interactions with nirmatrelvir-ritonavir in older adults using multiple medications

SB Ross, É Bortolussi-Courval, R Hanula… - JAMA network …, 2022 - jamanetwork.com
The antiviral nirmatrelvir-ritonavir reduces the risk of severe complications in high-risk,
symptomatic, unvaccinated adults with COVID-19. 1 However, the ritonavir component has …

Evaluation of oseltamivir used to prevent hospitalization in outpatients with influenza: a systematic review and meta-analysis

R Hanula, É Bortolussi-Courval, A Mendel… - JAMA Internal …, 2023 - jamanetwork.com
Importance Despite widespread use, summary evidence from prior meta-analyses has
contradictory conclusions regarding whether oseltamivir decreases the risk of hospitalization …

[HTML][HTML] MedSafer to support deprescribing for residents of long-term care: a mixed-methods study

GA Perri, É Bortolussi-Courval, CD Brinton… - Canadian Geriatrics …, 2022 - ncbi.nlm.nih.gov
Background Polypharmacy is prevalent in long-term care homes (LTCH) and increases the
risk of adverse drug events. Feasible and effective deprescribing interventions applicable in …

Deprescribing opportunities for hospitalized patients with end-stage kidney disease on hemodialysis: a secondary analysis of the MedSafer cluster randomized …

J Moryousef, É Bortolussi-Courval… - … Journal of Kidney …, 2022 - journals.sagepub.com
Background: End-stage kidney disease patients on dialysis have a substantial risk of
polypharmacy due their propensity for comorbidity and contact with the health care system. …

Diagnostic yield of CT head in delirium and altered mental status—A systematic review and meta‐analysis

…, SH Chaudhry, É BortolussiCourval… - Journal of the …, 2023 - Wiley Online Library
Background CT head is commonly performed in the setting of delirium and altered mental
status (AMS), with variable yield. We aimed to evaluate the yield of CT head in hospitalized …

[HTML][HTML] Observational versus randomized controlled trials to inform antibiotic treatment durations: a narrative review

…, C Prosty, R Hanula, É Bortolussi-Courval… - Clinical Microbiology …, 2023 - Elsevier
Background Studies comparing shorter and longer antibiotic treatment durations are increasingly
common. Randomized controlled trials (RCTs) are an ideal methodological approach …

Fluvoxamine for outpatient COVID-19 to prevent hospitalization: a systematic review and meta-analysis

TC Lee, S Vigod, É Bortolussi-Courval, R Hanula… - MedRxiv, 2021 - medrxiv.org
Importance Widely available and affordable options for the outpatient management of COVID-19
are needed, particularly therapies that prevent hospitalization. Objective Perform a meta…